Arabinda Guha

Title: The Innovations of Arabinda Guha

Introduction

Arabinda Guha is a notable inventor based in Pelham Manor, NY (US). He has made significant contributions to the field of medical science, particularly in the area of fibrinolytic activity. His work has implications for treating conditions related to blood clotting.

Latest Patents

Arabinda Guha holds a patent for a human serum plasminogen activator. This plasminogen proactivator has been isolated from mammalian and avian plasma, especially human plasma. It is characterized as a single, electrophoretically and immunologically homogeneous protein within a given species. The activator serves as a catalyst to initiate fibrinolytic activity in plasma, making it useful for controlling clotting in conditions such as venous thrombosis or arterial occlusion. Additionally, it aids in diagnosing conditions that predispose individuals to thromboembolic phenomena. The proactivator boasts a long useful in vivo half-life, providing a reservoir for maintaining the fibrinolytic potential of blood. Arabinda Guha has 1 patent to his name.

Career Highlights

Arabinda Guha is affiliated with The Rockefeller University, where he continues to advance his research and innovations. His work has garnered attention in the scientific community for its potential applications in medicine.

Collaborations

Some of his notable coworkers include Edward Reich and Wolf-Dieter Schleuning. Their collaborative efforts have contributed to the advancements in the field of fibrinolytic research.

Conclusion

Arabinda Guha's contributions to medical science through his patent on human serum plasminogen activator highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the understanding and treatment of blood clotting disorders.